ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Elicio Announces IND for Vaccine Targeting Mutated KRAS Cancers
March 01, 2021Elicio Therapeutics has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for ELI-002. ELI-002 is an Amphiphile (AMP) KRAS therapeutic vaccine containing AMP mKRAS peptides and a proprietary AMP CpG ... -
Elicio’s lymph node targeting candidate joins Covid-19 vaccine race
August 21, 2020Elicio Therapeutics has reported promising findings from preclinical studies of ELI-005, a protein subunit, lymph node targeting Covid-19 vaccine candidate.
Pharma Sources Insight January 2025
